Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Heart Fail Clin. 2010 Oct;6(4):401–413. doi: 10.1016/j.hfc.2010.05.002

List 2.

Exclusionary criteria for the Pediatric Cardiomyopathy Registry

• Endocrine disease known to cause heart muscle disease (including infants of diabetic
mothers).
• A history of rheumatic fever.
• Toxic exposures known to cause heart muscle disease (e.g., anthracyclines,
mediastinal radiation, iron overload, or heavy metal exposure).
• HIV infection or born to an HIV positive mother.
• Kawasaki disease.
• Congenital heart defects unassociated with malformation syndromes (e.g., valvar heart
disease or congenital coronary artery malformations).
• Immunologic disease.
• Invasive cardiothoracic procedures or major surgery during the preceding month
except those specifically related to cardiomyopathy including LVAD, ECMO and AICD
placement.
• Uremia, active or chronic.
• Abnormal ventricular size or function that can be attributed to intense physical training
or chronic anemia.
• Chronic arrhythmia unless there are studies documenting inclusion criteria prior to the
onset of arrhythmia (except a patient with chronic arrhythmia, subsequently ablated,
whose cardiomyopathy persists after two months is not to be excluded).
• Malignancy.
• Pulmonary parenchymal or vascular disease (e.g., cystic fibrosis, cor pulmonale, or
pulmonary hypertension).
• Ischemic coronary vascular disease.
• Age less than 18 years.
• Association with drugs known to cause hypertrophy (e.g., growth hormone,
corticosteroids or cocaine)
• Left ventricular assist device; extracorporeal membrane oxygenation; automatic
implantable cardioverter defibrillator.